Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
PDL BIOPHARMA, INC. (0000882104)
Standardized SEC financial data for PDL BIOPHARMA, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000882104 · Biological Products, (No Diagnostic Substances).
Gross margin
43.7%
Operating margin
-166.5%
Net margin
-229.3%
Revenue growth (YoY)
-4.1%
Return on equity
-16.6%
ROIC
-13.5%
Free cash flow
-$28.4M
Debt / equity
0.00×
Ratios for fiscal year 2019, standardized from SEC filings.